About Agios Pharmaceuticals (adapted from Agios Pharmaceuticals prospectus):
They are a biopharmaceutical company passionately committed to applying their scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and inborn errors of metabolism which are a subset of orphan genetic metabolic diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.